Tower Research Capital LLC (Trc) Aldeyra Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,426 shares of ALDX stock, worth $28,060. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,426
Previous 3,304
33.96%
Holding current value
$28,060
Previous $17,000
29.41%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding ALDX
# of Institutions
127Shares Held
37.6MCall Options Held
757KPut Options Held
539K-
Perceptive Advisors LLC New York, NY9.28MShares$58.8 Million1.54% of portfolio
-
Knoll Capital Management, LLC Miami, FL5.48MShares$34.7 Million17.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.76MShares$23.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$23 Million0.0% of portfolio
-
Kennedy Capital Management, Inc. St Louis, MO1.47MShares$9.31 Million0.17% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $370M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...